Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

被引：0
|
作者：
Kentaro Sudo
Ryusuke Hara
Kazuyoshi Nakamura
Emiri Kita
Akiko Tsujimoto
Taketo Yamaguchi
机构：
[1] Chiba Cancer Center,Department of Gastroenterology
[2] Chiba Cancer Center,Department of Radiation Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Pancreatic cancer; Gemcitabine; S-1; Chemoradiotherapy; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 202
页数：7
相关论文
共 50 条
  • [41] A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
    Chigusa Morizane
    Takuji Okusaka
    Junji Furuse
    Hiroshi Ishii
    Hideki Ueno
    Masafumi Ikeda
    Kohei Nakachi
    Mina Najima
    Takashi Ogura
    Eiichiro Suzuki
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 313 - 319
  • [42] Combination Chemoherapy with S-1 and Gemcitabine for Locally Advanced and/or Metastatic Unresectable Pancreatic Cancer
    Takayama, Yukiko
    Shimizu, Kyoko
    Tahara, Junko
    Oyama, Hiroyasu
    Hayashi, Kazuhiko
    Shiratori, Keiko
    GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [43] Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer
    Shin, Sang Joon
    Kim, Nam Kyu
    Keum, Ki Chang
    Kim, Ho Geun
    Im, Jun Seok
    Choi, Hye Jin
    Baik, Seung Hyuk
    Choen, Jae Hee
    Jeung, Hei-Cheul
    Rha, Sun Young
    Roh, Jae Kyung
    Chung, Hyun Cheol
    Ahn, Joong Bae
    RADIOTHERAPY AND ONCOLOGY, 2010, 95 (03) : 303 - 307
  • [44] A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
    Ueno, M.
    Okusaka, T.
    Omuro, Y.
    Isayama, H.
    Fukutomi, A.
    Ikeda, M.
    Mizuno, N.
    Fukuzawa, K.
    Furukawa, M.
    Iguchi, H.
    Sugimori, K.
    Furuse, J.
    Shimada, K.
    Ioka, T.
    Nakamori, S.
    Baba, H.
    Komatsu, Y.
    Takeuchi, M.
    Hyodo, I.
    Boku, N.
    ANNALS OF ONCOLOGY, 2016, 27 (03) : 502 - 508
  • [45] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Kei Saito
    Hiroyuki Isayama
    Yoshihiro Sakamoto
    Yousuke Nakai
    Kazunaga Ishigaki
    Mariko Tanaka
    Takeyuki Watadani
    Junichi Arita
    Naminatsu Takahara
    Suguru Mizuno
    Hirofumi Kogure
    Hideaki Ijichi
    Keisuke Tateishi
    Minoru Tada
    Kiyoshi Hasegawa
    Masashi Fukayama
    Norihiro Kokudo
    Kazuhiko Koike
    Medical Oncology, 2018, 35
  • [46] A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
    Saito, Kei
    Isayama, Hiroyuki
    Sakamoto, Yoshihiro
    Nakai, Yousuke
    Ishigaki, Kazunaga
    Tanaka, Mariko
    Watadani, Takeyuki
    Arita, Junichi
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Hasegawa, Kiyoshi
    Fukayama, Masashi
    Kokudo, Norihiro
    Koike, Kazuhiko
    MEDICAL ONCOLOGY, 2018, 35 (07)
  • [47] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Noriyuki Hirahara
    Takeshi Matsubara
    Shunsuke Kaji
    Tetsu Yamamoto
    Ryoji Hyakudomi
    Kiyoe Takai
    Kazunari Ishitobi
    Yuki Uchida
    Yoshitsugu Tajima
    BMC Cancer, 21
  • [48] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Takai, Kiyoe
    Ishitobi, Kazunari
    Uchida, Yuki
    Tajima, Yoshitsugu
    BMC CANCER, 2021, 21 (01)
  • [49] A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
    Takahiro Goji
    Tetsuo Kimura
    Hiroshi Miyamoto
    Masanori Takehara
    Kaizo Kagemoto
    Yasuyuki Okada
    Jun Okazaki
    Yoshifumi Takaoka
    Yoshihiko Miyamoto
    Yasuhiro Mitsui
    Sayo Matsumoto
    Tatsuhisa Sueuchi
    Kumiko Tanaka
    Yasuteru Fujino
    Toshi Takaoka
    Shinji Kitamura
    Koichi Okamoto
    Masako Kimura
    Masahiro Sogabe
    Naoki Muguruma
    Toshiya Okahisa
    Yasuhiro Sato
    Tamotsu Sagawa
    Koji Fujikawa
    Yasushi Sato
    Hitoshi Ikushima
    Tetsuji Takayama
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 615 - 620
  • [50] A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
    Goji, Takahiro
    Kimura, Tetsuo
    Miyamoto, Hiroshi
    Takehara, Masanori
    Kagemoto, Kaizo
    Okada, Yasuyuki
    Okazaki, Jun
    Takaoka, Yoshifumi
    Miyamoto, Yoshihiko
    Mitsui, Yasuhiro
    Matsumoto, Sayo
    Sueuchi, Tatsuhisa
    Tanaka, Kumiko
    Fujino, Yasuteru
    Takaoka, Toshi
    Kitamura, Shinji
    Okamoto, Koichi
    Kimura, Masako
    Sogabe, Masahiro
    Muguruma, Naoki
    Okahisa, Toshiya
    Sato, Yasuhiro
    Sagawa, Tamotsu
    Fujikawa, Koji
    Sato, Yasushi
    Ikushima, Hitoshi
    Takayama, Tetsuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 615 - 620
12345